GlassScriptPhysician profile
Alison D Kucich
NPI 1720029101
$3,880.70
in general payments reported to CMS, 2019-2025
37 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,028 · 2020: $376 · 2021: $713 · 2022: $868 · 2023: $506 · 2024: $265 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $868.05 | 2020-2024 | |
| Novo Nordisk INC | $511.51 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $458.33 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $275.26 | 2019-2023 | |
| Astellas Pharma US INC | $229.98 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $203.04 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $192.19 | 2019-2022 | |
| Abbott Laboratories | $139.59 | 2021-2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.29 | 2019-2020 | |
| Lilly USA, LLC | $116.58 | 2019-2024 | Jardiance |
| Amgen INC. | $68.15 | 2019-2025 | Evenity |
| Sunovion Pharmaceuticals INC. | $54.75 | 2019-2022 | |
| Abiomed | $46.10 | 2022 | |
| Dexcom, INC. | $41.38 | 2022-2024 | Dexcom G6 Transmitter |
| Eisai INC. | $39.92 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $39.51 | 2022 | |
| Allergan, INC. | $36.97 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $35.42 | 2021-2022 | |
| Convatec INC. | $34.95 | 2025 | |
| Inspire Medical Systems, INC. | $30.77 | 2025 | Inspire |
| Kowa Pharmaceuticals America, INC. | $29.54 | 2022 | |
| Nestle Healthcare Nutrition INC. | $29.23 | 2022 | |
| Cranial Technologies, INC | $28.82 | 2019-2021 | |
| Genentech USA, INC. | $26.55 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $24.30 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.37 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.28 | 2022 | |
| Phadia US INC. | $18.50 | 2022 | |
| Alexion Pharmaceuticals, INC. | $17.02 | 2020 | |
| Horizon Therapeutics Plc | $16.91 | 2023 | Krystexxa |
| Insulet Corporation | $16.59 | 2022 | |
| Exact Sciences Corporation | $16.47 | 2023 | Cologuard Collection Kit |
| Amneal Pharmaceuticals LLC | $14.68 | 2023 | Unithroid |
| Shield Therapeutics INC | $14.52 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.46 | 2019 | |
| Hologic Sales and Service, LLC | $13.74 | 2019 | |
| Mylan Specialty L.P. | $12.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Kucich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.